
Drug Addiction Treatment Market Report 2026
Global Outlook – By Type Of Drug Addiction (Opioid Addiction, Benzodiazepine Addiction, Barbiturate Addiction, Other Types), By Treatment Type (Inpatient Rehabilitation, Outpatient Rehabilitation, Detoxification Services, Aftercare And Continuity Programs, Medication-Assisted Treatment (MAT)), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Other Distribution Channels), By End-User (Rehabilitation Centers, Hospitals, Clinics, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035
Drug Addiction Treatment Market Overview
• Drug Addiction Treatment market size has reached to $22.9 billion in 2025 • Expected to grow to $36.32 billion in 2030 at a compound annual growth rate (CAGR) of 9.6% • Growth Driver: Rising Substance Use Disorders Driving The Growth Of The Market Due To Increasing Drug Consumption And Mental Health Challenges • Market Trend: New Medication-Assisted Treatment Services Expand Access For Opioid Use Disorder Patients • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Drug Addiction Treatment Market?
Drug addiction treatment refers to the professional medical and therapeutic interventions designed to help individuals stop or reduce substance use, manage withdrawal symptoms, and achieve long-term recovery and rehabilitation. Drug addiction treatment is utilized to help individuals overcome substance dependence, restore physical and mental health, and reintegrate into society through structured medical and therapeutic programs. The main types of drug addiction treatment are opioid addiction, benzodiazepine addiction, barbiturate addiction, and others. Opioid addiction refers to a chronic disorder characterized by the compulsive use of opioids despite harmful consequences, leading to physical dependence and psychological cravings. Treatment options include inpatient rehabilitation, outpatient rehabilitation, detoxification services, aftercare and continuity programs, and medication-assisted treatment (MAT), with various routes of administration include oral, parenteral, and others. Drug addiction treatments are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and others, with the key end-users being rehabilitation centers, hospitals, clinics, and others.
What Is The Drug Addiction Treatment Market Size and Share 2026?
The drug addiction treatment market size has grown strongly in recent years. It will grow from $22.9 billion in 2025 to $25.17 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to rising prevalence of substance abuse disorders, expansion of rehabilitation infrastructure, increased availability of detoxification services, growing public health awareness initiatives, wider acceptance of structured addiction treatment programs.What Is The Drug Addiction Treatment Market Growth Forecast?
The drug addiction treatment market size is expected to see strong growth in the next few years. It will grow to $36.32 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing demand for personalized addiction treatment plans, rising integration of digital health platforms, expansion of community-based rehabilitation services, growing focus on mental health parity, increased government funding for addiction recovery programs. Major trends in the forecast period include increasing adoption of medication-assisted treatment programs, rising integration of behavioral and psychological therapies, growing expansion of outpatient and community-based care models, enhanced focus on long-term aftercare and relapse prevention, increasing use of digital monitoring and support tools.Global Drug Addiction Treatment Market Segmentation
1) By Type Of Drug Addiction: Opioid Addiction, Benzodiazepine Addiction, Barbiturate Addiction, Other Types 2) By Treatment Type: Inpatient Rehabilitation, Outpatient Rehabilitation, Detoxification Services, Aftercare And Continuity Programs, Medication-Assisted Treatment (MAT) 3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration 4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Other Distribution Channels 5) By End-User: Rehabilitation Centers, Hospitals, Clinics, Other End-Users Subsegments: 1) By Opioid Addiction: Prescription Opioid Addiction, Synthetic Opioid Addiction, Heroin Addiction 2) By Benzodiazepine Addiction: Alprazolam Addiction, Diazepam Addiction, Lorazepam Addiction, Clonazepam Addiction 3) By Barbiturate Addiction: Amobarbital Addiction, Pentobarbital Addiction, Phenobarbital Addiction, Secobarbital Addiction 4) By Other Types: Cannabis Addiction, Cocaine Addiction, Hallucinogen Addiction, Inhalant Addiction, Stimulant AddictionWhat Is The Driver Of The Drug Addiction Treatment Market?
The increasing prevalence of substance use disorders is expected to propel the growth of the drug addiction treatment market going forward. Substance use disorders refer to chronic conditions characterized by the compulsive use of drugs or alcohol despite harmful consequences, significantly affecting a person’s mental, physical, and social well-being. The rising prevalence of substance use disorders is due to rising stress and mental health issues, along with modern lifestyles characterized by social pressures, economic instability, and easy access to addictive substances. Drug addiction treatment helps substance use disorders by providing medical and psychological support to reduce dependency, improve overall well-being, and support long-term recovery through structured rehabilitation. For instance, in December 2023, according to the Office for Health Improvement & Disparities (OHID), a UK-based public health agency, between April 2022 and March 2023, a total of 290,635 adults engaged with drug and alcohol services, representing a slight increase from 289,215 in the previous year. Therefore, the increasing prevalence of substance use disorders is expected to propel the growth of the drug addiction treatment industry.Key Players In The Global Drug Addiction Treatment Market
Major companies operating in the drug addiction treatment market are Novartis AG, Dr. Reddy’s Laboratories Ltd., Acadia Healthcare, Hikma Pharmaceuticals plc, Alkermes plc, Indivior PLC, Emergent BioSolutions Inc., Workit Health, Rusan Pharma Pvt. Ltd., Boulder Care, Bicycle Health, Eleanor Health, Affect Therapeutics, Forge Health, Orexo AB, BioCorRx Inc., Kinoxis Therapeutics Pty. Ltd., Addinex Technologies Inc., PursueCare, Aliya Health GroupGlobal Drug Addiction Treatment Market Trends and Insights
Major companies operating in the drug addiction treatment market are focusing on technological advancements, such as telehealth appointments, to increase accessibility, improve patient engagement, and provide convenient, remote treatment for individuals with substance use disorders. Telehealth appointments refer to medical consultations and healthcare services conducted remotely using digital communication technologies. For instance, in February 2023, Jovive Health, a US-based multispecialty healthcare provider, launched Medication-Assisted Treatment (MAT) services for patients with Opioid Use Disorder (OUD) across its clinics in California, Nevada, and Illinois. The program uses FDA-approved medications such as buprenorphine to reduce withdrawal symptoms and cravings, helping patients safely stop opioid use. Jovive’s launch features include multi-appointment individualized treatment plans, convenient online booking, walk-in consultations, extended clinic hours, and telehealth appointments, making OUD treatment more accessible and patient-centric.What Are Latest Mergers And Acquisitions In The Drug Addiction Treatment Market?
In March 2023, Indivior PLC, a US-based pharmaceutical company, acquired Opiant Pharmaceuticals, Inc. for an undisclosed amount. Through this acquisition, Indivior strengthens its addiction treatment portfolio by adding Opiant’s late-stage assets, including OPNT003, a novel investigational opioid overdose treatment, and gains a talented team to advance its mission of providing life-transforming therapies for substance use disorders. The deal also positions Indivior for potential revenue growth from OPNT003 and expands its pipeline with additional investigational treatments for alcohol and cannabinoid use disorders. Opiant Pharmaceuticals, Inc., is a US-based specialty pharmaceutical company that develops pharmacological treatments for substance use, addictive, and eating disorders.Regional Outlook
North America was the largest region in the drug addiction treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Drug Addiction Treatment Market?
The drug addiction treatment market includes revenues earned by entities by providing services such as counseling and psychotherapy services, behavioral therapy programs, family support and intervention services, telehealth and virtual recovery services, and relapse prevention and monitoring programs. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Drug Addiction Treatment Market Report 2026?
The drug addiction treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the drug addiction treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Drug Addiction Treatment Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $25.17 billion |
| Revenue Forecast In 2035 | $36.32 billion |
| Growth Rate | CAGR of 9.9% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type Of Drug Addiction, Treatment Type, Route Of Administration, Distribution Channel, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Novartis AG, Dr. Reddy’s Laboratories Ltd., Acadia Healthcare, Hikma Pharmaceuticals plc, Alkermes plc, Indivior PLC, Emergent BioSolutions Inc., Workit Health, Rusan Pharma Pvt. Ltd., Boulder Care, Bicycle Health, Eleanor Health, Affect Therapeutics, Forge Health, Orexo AB, BioCorRx Inc., Kinoxis Therapeutics Pty. Ltd., Addinex Technologies Inc., PursueCare, Aliya Health Group |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
